Johnson & Johnson’s consumer health business Kenvue Inc. has priced its initial public offering at $22 per share, according to people familiar with the matter.
That’s at the top half of the $20-to-$23-a-share range that the company’s advisers had cited in marketing the 151 million shares it plans to sell in the listing. At that size, the listing would raise about $3.3 billion, the biggest IPO of 2023. The people declined to comment because the details aren’t public.
https://www.bloomberg.com/news/articles/2023-05-03/j-j-s-kenvue-is-said-to-price-ipo-at-22-per-share
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.